Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral deferasirox + deferiprone combination chelation in transfusion-dependent thalassemia refractory to monotherapy
TCTR20261012006Phase 3Not yet recruiting
- Sponsor
- Chiang Mai University
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deferasirox, deferiprone in Thalassaemia, iron overload, sponsored by Chiang Mai University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
deferasiroxdeferiprone
03
Conditions
Thalassaemiairon overload
Beyond the preview
Go deeper on TCTR20261012006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261012006.